Carnethon MR, De Chavez PJD, Lauderdale DS, Carson AP, Liu K, Knutson KL
Key Takeaways GLP-1 medications can make it easier to eat less, but steep calorie deficits may cause muscle loss alongside fat loss
In the phase II double-blind, placebo-controlled THEMATIC trial, fecal microbiota transplantation was safe in patients with cirrhosis and recurrent HE, with no treatment-related adverse events [151]
Today, our Medical Advisory Board member, Alexander Tatem, was one of the few on the ground testifying at the FDA's PCAC meeting advocating for science-driven, physician-guided access to innovative peptide therapies that help men optimize their long-term health
Item Features: 100% Brand New, Exactly As Shown In The Picture
45,46 This result was confirmed by the recent pooled analysis of the STEP HFpEF and STEP HFpEF DM trials, which included 1,145 patients